Dr Reddy’s and Nestle launch Celevida GLP+ for diabetes and obesity patients

Published on 7 May 2026

A new supplement targets hurdles during GLP 1 GIP therapy

Dr Reddy’s has joined forces with Nestle Health Science to roll out Celevida GLP+, a nutrition supplement designed for people managing type 2 diabetes and obesity while on GLP-1/GIP therapy. The collaboration aims to address day to day nutritional challenges that can emerge during treatment, adding a targeted option beyond standard diabetes and weight management care.

Dr Reddy’s partners with Nestle Health Science to launch Celevida GLP+
The supplement is designed for type 2 diabetes and obesity
It is targeted at patients navigating GLP 1 GIP therapy challenges

#nestle health science #obesity #diabetes #nutrition #dr reddys

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Dr Reddy’s and Nestle launch Celevida GLP+ for diabetes and obesity patients

The full experience is on mobile.